Days
Hours
Minutes
Seconds
March 1 & 2, 2024
About
Desert Liver Retreat
We provide a superior scientific program and a fun opportunity to network with colleagues seeking an update in state-of-the-art liver disease care. Our exhibitors are chosen as excellent providers of important products and services to our community.
Target Audience
This event is intended for MDs, DOs, PAs, NPs, RNs, residents, fellows, and clinical research personnel who are involved in the care of patients with liver disease.
Educational Objectives
After attending this event the participant should be better able to:
Utilize most recent guidelines for screening and diagnosing patients at risk of chronic liver disease
Develop an evidence-based treatment regimen for chronic liver disease using latest clinical evidence
Communicate disease and treatment options to patients
Recognize and communicate risks and benefits of therapy
Recognize differential diagnosis for NAFLD & NASH
Characterize risk factors for PBC & be able to discuss different therapies for PBC
Identify diagnostic approaches for HCC and treatment options
Explain diagnostic criteria and diagnostic tools for minimal and overt HE
Define diagnostic and therapeutic strategies for HCC
Demonstrate understanding of the diagnostic approaches for PSC and the role of liver biopsy as well as what therapies are used for PSC and when
Demonstrate understanding of different currently available treatment options for different clinical manifestations of portal hypertension
Choose different interventions and treatment approaches to minimize inpatient health care utilization for patients with liver disease
Describe the hepatic manifestations of COVID-19 infections including acute hepatic injury and cholangitis
2023 - Jointly provided by Pinnacle Clinical Research, PLLC.
Educational grant support is pending and any confirmed support received will be disclosed in future course materials.
Accreditation Statements
Coming Soon
Physician Assistant Continuing Medical Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 7 CME credits for activities planned in accordance with AAPA CME Criteria.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 7.0 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses to be determined.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Disclosures
Coming Soon
2024 Agenda
Friday, March 1 - Steatotic Liver Disease Summit/ Noninvasive Tests (NITs) Workshop
1:00 AM - 1:05 PM
Opening Remarks
Stephen Harrison, MD, FACP, FAASLD
1:05 PM - 1:30 PM
Imaging NITs
Mazen Noureddin, MD, MHSc
1:30 PM - 1:55 PM
Serologic NITs
Meena Bansal, MD
1:55 PM - 2:20 PM
Selecting Patients for Treatment and Monitoring Response
Naim Alkhouri, MD, FAASLD or Stephen Harrison, MD, FACP, FAASLD
2:20 PM - 2:50 PM
Interactive Cases
Stephen Harrison, MD, FACP, FAASLD & Naim Alkhouri, MD, FAASLD
2:50 PM- 3:10 PM
Break
3:10 PM - 4:30 PM
NITs Demonstration (Echosens/ e-Scopics/ Sonic Incytes/ Siemens/ OWL)
Naim Alkhouri, MD, FAASLD, Meena Bansal, MD, Stephen Harrison, MD, FACP, FAASLD, Mazen Noureddin, MD, MHSc
4:30 PM - 5:15 PM
Panel Discussion on the Future of MASH Therapeutics
Naim Alkhouri, MD, FAASLD, Meena Bansal, MD, Stephen Harrison, MD, FACP, FAASLD, Mazen Noureddin, MD, MHSc
Saturday, March 2 - Agenda
7:00 AM - 8:30 AM
Registration & Exhibits
7:30 AM - 8:30 AM
Product Theater and Breakfast
8:30 AM - 8:35 AM
Opening Remarks
Naim Alkhouri, MD, FAASLD
SESSION ONE
(DILI/ Metabolic/ and Liver Transplant)
Moderator: Stephen Harrison, MD, FAASLD
Panelists: Richard Manch, MD, FAASLD, FACP, FACG, Naga Chalasani, Moises (IIan) Nevah Rubin, MD
8:35 AM - 9:00 AM
Drug Induced Liver Injury
Raj Vuppalanchi, MD
9:00 AM - 9:25 AM
The Big 3 of Genetic Liver Diseases: Hemochromatosis/ A1ATD/ Wilson Disease
Richard Manch, MD, FAASLD, FACP, FACG
9:25 AM - 9:50 AM
Liver Transplant for the Non-Specialist
Moises (IIan) Nevah Rubin, MD
9:50 AM - 10:15 AM
Panel Discussion
10:15 AM - 10:30 AM
Break & Exhibits in Foyer
SESSION TWO
MASLD and MASH
Moderator: Naim Alkhouri, MD, FAALSD
Panelists: Meena Bansal, MD,
Mazen Noureddin, MD, MHSc
Stephen Harrison, MD, FACP, FAASLD, Naim Alkhouri, MD, FAALSD
10:30 AM - 10:50 AM
Steatotic Liver Desease (SLD) New Nomenclature: Implications and Implementation
Meena Bansal, MD
10:50 AM - 11:10 AM
All You Need to Know on Diagnosing MASLD: From Risk Stratification to Treatment Monitoring
Mazen Noureddin. MD
11:10 AM - 11:30 AM
Management of MASH with New Drugs: The Future Is Bright
Stephen Harrison, MD, FACP, FAASLD
11:30 AM - 12:00 PM
Practical SLD Cases and Panel Discussion
Naim Alkhouri, MD, FAASLD
12:15 PM - 12:30 PM
Panel Discussion
12:00 PM - 1:15 PM
Product Theater, Lunch, & Exhibits
SESSION THREE
Viral Hepatitis and Cholestasis
Moderator: Anita Kohli, MD
Panelists: Julio Gutierrez, MD, Raj Vuppalanchi, MD,
Naim Alkhouri, MD, FAASLD
1:15 PM - 1:35 PM
Treatment for HBV/HDV: Are we Close to a Cure?
Julio Gutierrez, MD
1:35 PM - 1:50 PM
HCV Elimination: Where are we?
Anita Kohli, MD
1:50 PM - 2:15 PM
PBC Update: New Drugs Coming Your Way Soon
Raj Vuppalanchi, MD
2:15 PM - 2:40 PM
Genetic Cholestasis for the Adult Provider
Kelly Dale, NP
2:40 PM - 3:00 PM
Panel Discussion
3:00 PM - 3:30 PM
Break & Exhibits in Foyer
SESSION FOUR
Cirrhosis
Moderator: Jacqueline O'Leary, MD Panelists: Elliot Tapper, MD, Jinendra Satiya, MD
3:30 PM - 3:55 PM
Cirrhosis/ Portal Hypertension Update: From HRS to HCC
Jacqueline O'Leary, MD, MPH
3:55 PM - 4:20 PM
Management of the Forgotton Symptoms of Cirrhosis: From Sarcopenia to Cramps and Beyond.
Elliot Tapper, MD
4:20 PM- 4:45 PM
Pulmonary Complications of Liver Disease
Jinendra Satiya, MD
4:45 PM - 5:00 PM
Panel Discussion
5:00 PM
Concluding Remarks
Reception to Follow for Registered Attendees and Sponsors
Course Directors
2023 Desert Liver Conference Faculty
Dr. Moises (Ilan) Nevah Rubin
Dr. Raj Vuppalanchi
Kelly Dale, NP
2024 Fees
Registration Fees
Early Bird Before 12/30
Regular After 12/30
In-person attendance (includes CME/MOC) ++ may be subject to facility and service fees
$125++
$150++
In-person attendance, CEU, non-CME (nurses, fellows/students, and others not requesting CME credits, research personnel) ++ may be subject to facility and service fees
$75++
$100++
Virtual attendance (includes CME and non-CME) ++ may be subject to facility and service fees
$100++
$125++
Thank You 2024 Diamond Sponsors
Thank You 2024 Top Sponsor
Thank You 2024 Platinum Sponsors
Thank You 2024 Gold Sponsor
Thank You 2024 Silver Sponsors
